Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

Clinical trial NCT00923091 · COMPLETED

Trial details

NCT number: NCT00923091
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2009-06-01
Primary completion: 2011-01-01
Enrollment: 2689

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.